![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » KV PHARMACEUTICAL COMPANY LICENSES TWO WOMEN'S HEALTH PRODUCTS FOR MARKETING IN MEXICO
KV PHARMACEUTICAL COMPANY LICENSES TWO WOMEN'S HEALTH PRODUCTS FOR MARKETING IN MEXICO
KV Pharmaceutical announced today that it has entered into agreements with Representaciones E Investigaciones Medica for the granting of licensing rights in Mexico for KV's two single dose prescription vaginal cream products, U.S. market leader Gynazole-1 and the recently FDA-approved Clindesse. KV will receive licensing fees and manufacturing revenues under the terms of the agreement with RIMSA for both products.
Yahoo News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct